Its possible that we get more deals replica watches like the one just announced. But we are not in it for pure OEM manufacturing, not at the moment anyway. You have mentioned omega replica in the past a $1Bn target by 2015. Going by the developments, you have successfully raised money, things look to be on track. What are the replica watches uk top 3 milestones/successes Opto Circuits is looking to achieve in that drive in the next 2-3 yearsis it -USFDA approval for DIOR/DES Stents (BMS stents are in the process) -large-scale rolex replica manufacturing for medical equipment biggies -dominating Indian market for Invasives? As we explained before Criticare revenues are set to double. The investments made in Criticare are beginning omega replica to show. We have a slew of products coming out. Opto Circuits now has a complete range of products for addressing the full needs of patient monitoring in all environments CCU, OT. We are cartier replica able to address opportunities which we earlier could not because of a limited range rolex replica are big worldwide tenders from bodies such as the WHO. Opto Circuits is one of the shortlisted vendors. In the replica belts coming 2 years the invasive products from EuroCor will be a big driver of growth. Opto Circuits is the first with CE omega replica approval for DIOR replica wallets (drug eluting balloon) and Magical stent+DIOR (which is a superior technology to the DES stent). Sales are dependent on clinical louis vuitton replica data from tests, acceptance with doctors rolex replica, there are major market development efforts/costs involved. More the tests data, the easier to find major acceptance, easier to sell. Competitors on this technology are atleast 2 years replica watches uk away from approval, so we are very hopeful that these may prove to be real disruptive products, as they offer louis vuitton replica significant benefits over existing technology.
Home
About Us
Our Director
From the Desk of Director
Staff Members
Annual Report
Publications
Ethical Guidelines
Events
Activities
Employment
Result
Committees
Tender Notice
RTI
Declaration of Assets and Liabilities by the Employees under Lokpal and Lokayukta Act 2013
Declaration of Immovable Property
Contact Us
Image Galleries
Related Links
Portal for Public Grievances
Circulars
Forms
Holidays -2015
 
 

National Institute for Research in Environmental Health(NIREH), Bhopal, is one of the permanent institutes of the Indian Council of Medical Research (ICMR), a Government of India’s apex autonomous organization for bio-medical research in the country.

Current News

"Guidelines for Representation from Government Servant on service matters"

Swachh Bharat Campaign" it has been decided to do “Shramdan” on every Friday between 4.30 – 5.30 PM to clean the NIREH building and its surroundings by the officials and staff members of NIREH (including project staff).

CS (MA) Rules

Fresh Empanelment of private healthcare organizations (HCOs) and revision of package rates applicable under CGHS, Bhopal (w.e.f. 17.11.2014)

List of AMAs/Recognised hospitals and Pathology Labs as approved by CGEWCC, Bhopal Revised list as on 1.4.15

All donations towards Prime Minister's National Relief Fund (PMNRF) are notified for 100% deduction from taxable income under Section 80G of Income Tax Act1961

 

Current News

Shortlisted candidates for interview for the two posts of Multi Tasking Staff (Field Attendatnt) under ICMR funded adhoc short term project entitled "A Hospital based congenital malformations in the neonates of gas exposed and non exposed mothers and their first generation progenies in Bhopal” For details Click here"

Public Notice regarding Environmental clearance from MPSEIAA advertised in News papers